Hendra and nipah infection: pathology, models and potential therapies. - sprookjes - yvandenbroek - TriplyDB

Hendra and nipah infection: pathology, models and potential therapies.

Hendra and nipah infection: pathology, models and potential therapies.

http://www.wikidata.org/entity/Q35658146

about

Comparison of the pathogenicity of Nipah virus isolates from Bangladesh and Malaysia in the Syrian hamster Fatal measles virus infection prevented by brain-penetrant fusion inhibitors.Electron tomography imaging of surface glycoproteins on human parainfluenza virus 3: association of receptor binding and fusion proteins before receptor engagement Mechanism of fusion triggering by human parainfluenza virus type III: communication between viral glycoproteins during entry Emerging paramyxoviruses: molecular mechanisms and antiviral strategies A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses.Paramyxovirus activation and inhibition of innate immune responses.Henipavirus receptor usage and tropism.Opportunities for bead-based multiplex assays in veterinary diagnostic laboratories.Measles virus fusion machinery activated by sialic acid binding globular domain.Activation of the Nipah virus fusion protein in MDCK cells is mediated by cathepsin B within the endosome-recycling compartment.Zoonotic Potential of Emerging Paramyxoviruses: Knowns and Unknowns.Biophysical Properties and Antiviral Activities of Measles Fusion Protein Derived Peptide Conjugated with 25-Hydroxycholesterol.Rescue and characterization of recombinant cedar virus, a non-pathogenic Henipavirus species.

P2860

Q27305274-97E6B3D5-5917-4A95-9A69-42575BB351D9 Q30557599-6133E730-DDC8-4AC8-9508-419A6C88C9C9 Q35111139-86134F83-6510-4EB3-B344-6B364C1A1DEC Q35643883-8DA01232-B7C4-4091-9CCC-11503BF3AA6F Q35658152-2A8517A2-BC2E-4A70-BA2F-A34705EE9FE3 Q37507215-7D6FCBFC-4F39-4B85-ABAD-620B36BA02A6 Q37613401-28C5F808-044F-4417-8B19-9355297659FB Q38018531-C53BE151-5DF3-479F-9BBA-3A490FD03C83 Q38155042-CB37EC56-A34A-4D3C-96E8-33460106E63D Q39083962-3638CA73-B3C7-4172-B58C-E2DD91DD7AFD Q39406187-31CDF7B3-01B5-4089-9D6D-9147B285B4BF Q40231964-CB9087F8-F991-487E-94FC-43E0CA0B5166 Q47582990-D1464607-F80D-4322-B775-AEF17E36AF1A Q55132682-02C76EDF-05AE-458C-9799-C6D376730A47

P2860

Hendra and nipah infection: pathology, models and potential therapies.

http://www.wikidata.org/entity/Q35658146

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Hendra and nipah infection: pathology, models and potential therapies.

@ast

Hendra and nipah infection: pathology, models and potential therapies.

@en

type

label

Hendra and nipah infection: pathology, models and potential therapies.

@ast

Hendra and nipah infection: pathology, models and potential therapies.

@en

altLabel

Hendra and nipah infection: pathology, models and potential therapies

@en

prefLabel

Hendra and nipah infection: pathology, models and potential therapies.

@ast

Hendra and nipah infection: pathology, models and potential therapies.

@en

P1433

Q35658146-745CCD4D-F2C0-41A3-898C-92D770267049

P1476

Q35658146-EFD41DF5-4CFF-480F-BDCA-FFE828489017

P2093

Q35658146-035D7BC6-8CFB-49D3-88C3-D47923535C3D

Q35658146-AFAF0C92-966C-4504-91D5-FF6C1613BFAB

P2860

Q35658146-0126F089-76DF-409A-94A5-60B2CB9325F5

Q35658146-01A84B0B-E459-4531-8D82-7F5CBF73A423

Q35658146-0387EF2D-F664-4822-BA75-5DBF9512D811

Q35658146-03E2D6F2-969E-455B-8588-90CF9A891918

Q35658146-03FC83CE-0D72-4802-861F-2BA440143483

Q35658146-059D85D1-2785-4633-83E4-0657FAB009F8

Q35658146-07188B26-F34B-480F-8A2B-E84E50A76F63

Q35658146-08037B4F-F075-4C44-AB77-62816E76497E

Q35658146-09B88C89-38DE-412E-BC4E-34E7B0F75EBC

Q35658146-0A8FD3C1-5D59-48BE-8863-8D67EC6FC7F2

P304

Q35658146-77BF0096-9BAD-4635-8487-6D5004D52C72

P31

Q35658146-2620E23A-4505-4FE1-8471-21862B48F18B

P356

Q35658146-7CA50505-21C2-4C91-926E-8FE1D436C400

P407

Q35658146-F51A20DD-45DE-4920-96F6-FBA6A381567F

P433

Q35658146-6BC35A3B-FB37-4A9B-8EBE-11D7C65C90F6

P478

Q35658146-7FBC2235-17A3-41F8-94CD-510704E9D73D

P577

Q35658146-32E832BB-57FC-4E4B-B834-6A5B1AAFC726

P5875

Q35658146-3D82E237-9172-4761-85C1-639DC486BD75

P698

Q35658146-AB9BCAAE-B566-4E25-8CD7-E5A60507736C

P921

Q35658146-2ceb27ca-59e2-4f48-b542-01cd560c6547

Q35658146-CB22F293-675C-493C-9B9C-08C2D31A8778

P932

Q35658146-A671FCA6-8FAD-44D0-9088-F71DE3D9C8E7

P356

187152611795768097

P1433

Infectious disorders drug targets

P1476

Hendra and nipah infection: pathology, models and potential therapies.

@en

P2093

Benhur Lee

http://www.w3.org/2001/XMLSchema#string

Frederic Vigant

http://www.w3.org/2001/XMLSchema#string

P2860

Henipavirus RNA in African bats

Evidence of henipavirus infection in West African fruit bats

Nipah Virus Encephalitis Outbreak in Malaysia

TAK-220, a novel small-molecule CCR5 antagonist, has favorable anti-human immunodeficiency virus interactions with other antiretrovirals in vitro.

Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus

An apparently new virus (family Paramyxoviridae) infectious for pigs, humans, and fruit bats

No strings attached: the ESCRT machinery in viral budding and cytokinesis

The promises and pitfalls of RNA-interference-based therapeutics

Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein.

Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus

P304

315-336

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/187152611795768097

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51047395

http://www.w3.org/2001/XMLSchema#string

P698

21488828

http://www.w3.org/2001/XMLSchema#string

P921

P932

3253017

http://www.w3.org/2001/XMLSchema#string